Georgi Roussev was appointed general manager of the stand-alone company within the group.
EPH will continue to operate as player on the pharmaceutical distribution market. Georgi Roussev played a major role in the completion of the transaction. In December 2013, he took over as Chief Financial Officer (CFO) at GSK Pharma and Europharm in Romania. In April 2016, he took over as divestment lead and CFO at EPH, according to a statement issued by Europharm Distributie.
Interbrands CEO Rand Sherif said EPH is not only a financially stable and solid company, but also one of the most important players on the pharmaceutical distribution market. Sherif also said Interbrands would support EPH both through investments and by capitalizing on all opportunities offered by this sector.
In October 2015, British pharmaceutical group GSK signed the agreement for the sale of Europharm to Interbrands. The transaction was approved by Romania’s Competition Council in March 2016.
EPH has been operating on the Romanian market for over 20 years, posting sales of EUR200 million. The company currently has some 500 employees working in 11 warehouses. It distributes over 3,500 products from 90 local and international suppliers and ensures delivery services to over 5,500 points of sale: independent pharmacies, pharmacy chains with national coverage, hospitals and other types of customers.
Interbrands Marketing & Distribution, part of Sarkis Group International, boasts business lines developed in Romania, Bulgaria, Cyprus, Belarus, Lebanon, Qatar, Iraq and Libya. It operates in the sector of FMCG distribution and marketing in Romania.